Epigenetics Market Poised for High Growth Due to Technological Advancements

 

    

The epigenetics market is concerned with the study of heritable modifications in gene expression that are not caused by changes in the DNA sequence. The increasing applications of epigenetics in disease treatment and diagnosis are driving the growth of the epigenetics market. Epigenetic modifications such as methylation, histone modifications, and microRNAs play a major role in regulating gene expression during development, cellular differentiation, oncogenesis, and other biological processes. Advances in sequencing technologies and bioinformatics approaches have enabled researchers to analyze genome-wide epigenetic patterns during various biological events. This increased understanding of epigenetic mechanisms has led to the identification of epigenetic biomarkers for various diseases including cancer. Moreover, epigenetic drugs are being developed for targeting abnormal epigenetic patterns in cancer and other diseases.

The Global epigenetics market is estimated to be valued at US$ 17.05 Bn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the epigenetics market are L€TMOreal S.A, Procter and Gamble Company (P&G), Estee Lauder Companies Inc., The Unilever Plc, Shiseido Co. Ltd., Johnson and Johnson Limited, Kose Corporation, and Kao Corporation. These key players are focusing on developing innovative epigenetic technologies and kits for various applications.

The increasing incidence of cancer and other chronic diseases has opened up opportunities for epigenetic diagnostic technologies and drugs. Global epigenetics market size biomarkers hold potential for non-invasive screening, early detection, and prognosis evaluation of cancers. Emerging areas such as epigenetic aging clocks, epigenetic toxicology, and epigenetic epidemiology are likely to gain more attention in the coming years.

The key players are expanding globally to gain access to new markets. Establishing R&D centers, acquisitions, and collaborations with global research organizations are some of the strategies adopted by companies to strengthen their global footprint. Asia Pacific region is expected to witness fastest growth owing to increasing healthcare expenditure and rising incidence of chronic diseases.

Market Drivers

The increasing prevalence of cancer and other chronic diseases is a major factor driving the growth of the epigenetics market. According to WHO, cancer is the second leading cause of death globally and accounted for 9.6 million deaths in 2018. Epigenetic modifications play a critical role in the onset and progression of various cancer types. Development of epigenetic markers for early cancer detection and epigenetic drugs targeting dysregulated epigenetic pathways are expected to boost the market growth.

Growing application of epigenetics in non-oncology areas such as metabolic disorders, infectious diseases, cardiovascular diseases is expected to present new opportunities. Advancements in epigenetic profiling and epigenomic technologies have increased the understanding of role of epigenetics in various pathological conditions driving the demand for epigenetic solutions.

Market Restrains

High costs associated with epigenetic tools, assays and procedures may hinder broader market adoption, especially in price-sensitive developing markets. Complexity of epigenetic processes and lack of qualified researchers are challenges faced by epigenetic solution providers. Stringent regulations for developing and commercializing epigenetic diagnostic kits and therapies also impede the market growth. Compared to genomics, epigenetic mechanisms are less understood posing technical hurdles for development of robust epigenetic applications.

Segment Analysis

The global epigenetics market is dominated by kits, reagents sub segment. This is because majority of research and development activities in epigenetics requires various kits and reagents such as bisulfite conversion kits, immunohistochemistry kits, polymerase chain reaction (PCR) reagents and Western blotting reagents. Chromatin remodelling and DNA modification processes involved in epigenetic studies to understand development and disease rely heavily on these kits and reagents. The next fastest growing sub segment is DNA modification enzymes which includes DNA methyltransferases and histone acetyltransferases. These enzymes play a crucial role in epigenetic modifications and understanding their function is critical for researching various disease conditions.

Global Analysis

The North America region dominated the global epigenetics market with highest market share in 2024. Presence of major biopharmaceutical companies and research organizations along with large healthcare expenditure contributes to its leading position. Additionally, supportive government initiatives of funding cancer research further supplements market growth in the region. Asia Pacific region is poised to grow at fastest CAGR during the forecast period on back of increasing research activities in countries such as China, India and Japan along with rising awareness about epigenetics role in personalized medicine. At country level, United States represented largest market. However, China is anticipated to register highest incremental growth during forecast period owing to establishing local manufacturing facilities by major players along with progressive government policies.

Get More Insights On This Topic: https://www.ukwebwire.com/epigenetics-market-size-share-analysis-2023-2030/


Comments

Post a Comment

Popular posts from this blog

Macrophage Marker Market Poised to Grow at a Robust Pace Due to Rising Demand in Medical Diagnostics

Image
  The macrophage marker market has witnessed significant growth in recent years owing to the growing applications of macrophage markers in medical diagnostics. Macrophage markers are proteins or cell surface receptors that are expressed by macrophages and are used to identify and study macrophages and their functions. Some of the key macrophage markers include CD14, CD68, CD163, CD206, and LAMP-3. These markers play a vital role in studying the functions of macrophages in various diseases like cancer, inflammatory disorders, and infectious diseases. The global macrophage marker market is estimated to be valued at US$ 295.15 million in 2024 and is expected to exhibit a CAGR of 2.7% over the forecast period of 2024-2030. The growing prevalence of various chronic and infectious diseases and increase in R&D spending for drug discovery are some of the key factors driving the demand for macrophage markers in recent years. Macrophage markers help in evaluating disease progression, drug
Read more

The global Cancer Diagnostics Market is growing at an accelerated pace

Image
  Cancer diagnostics involve various tests and procedures used to detect different types of cancers as early as possible to help improve treatment outcomes. From simple blood tests and imaging scans to biopsies and molecular testing, cancer diagnostics help doctors determine if an individual has cancer, where it is located in the body, if it has spread, and other important information. The growing incidences of various cancers like breast, lung, prostate and colorectal cancer globally have increased the demand for advanced and effective diagnostic procedures. Early detection is critical for cancers to treat them effectively and improve chances of survival. The global Cancer Diagnostics Market is estimated to be valued at US$ 59.1 Bn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Immunohistochemistry is one of the key diagnostic trends gaining populari
Read more

The Global Boat Accumulator Market Growth Is Accelerated By Increasing Consumer Spending

Image
  Boat accumulators or batteries are sealed lead acid batteries that provide starting power and deep cycle power for boats. They are essential for powering marine electrical systems, motors, navigation lights, bilge pumps and other onboard appliances. The growing marine tourism and recreational boating activities have increased the demand for boats and yachts over the years. This has propelled the boat accumulator market. The global Boat Accumulator Market is estimated to be valued at US$ 266.66 Mn in 2023 and is expected to exhibit a CAGR of 2.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Increasing consumer spending on recreational boating activities has been a major driver for the boat accumulator market over the past decade. The number of recreational boats sold globally has increased steadily with the rise in disposable incomes and leisure time among consumers. Countries like the United State
Read more